John Couling - 15 Nov 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
SVP, Entertainment
Signature
/s/ Daniel Rodriguez, Attorney-in-Fact for John Couling
Issuer symbol
DLB
Transactions as of
15 Nov 2023
Transactions value $
-$6,998
Form type
4
Filing time
17 Nov 2023, 16:10:41 UTC
Previous filing
16 May 2023
Next filing
19 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale -$6,997 -79 -0.08% $88.58 96,370 15 Nov 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transaction include 43,636 restricted stock units, which are subject to forfeiture until they vest.
F2 Shares include (1) 87 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021, (2) 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022, and (3) 79 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2023. The shares acquired on November 15, 2021 and November 15, 2022 were not included in share totals reported previously due to administrative error.

Remarks:

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 17, 2022, as amended February 6, 2023, which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.